InflaRx
-$0.01 (-0.36%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell InflaRx and other ETFs, options, and stocks.
About IFRX
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a. Its products include IFX-1 and IFX-2.
CEO
Niels Christoph Riedemann
Employees
49
Headquarters
Jena, Thueringen
Founded
2007
IFRX Key Statistics
Market Cap
121.07M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
485.67K
High Today
$2.80
Low Today
$2.71
Open Price
$2.78
Volume
92.94K
52 Week High
$6.88
52 Week Low
$2.23
Analyst Ratings
67%
of 6 ratings
Buy
66.7%
Hold
0%
Sell
33.3%
IFRX Earnings
-$0.52
-$0.35
-$0.17
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Oct 28, Pre-Market